Skip to main content

Alzheimer's Disease

Volume 455: debated on Tuesday 16 January 2007

To ask the Secretary of State for Northern Ireland what criteria are used when determining the prescription of Reminyl to patients with Alzheimer’s disease on the NHS in Northern Ireland. (115557)

Reminyl is available on prescription in Northern Ireland following examination and recommendation by a consultant, taking account of evidence-based practice and the needs of the patient. Consultants generally apply a test known as the Mini Mental State Examination which, together with functional and behavioural assessment of the patient, helps inform their decision on the prescription of drugs in individual cases.

The availability of drugs to treat people with Alzheimer’s disease, including Reminyl, is currently being reviewed by my Department in light of the recent NICE technology appraisal on drugs for Alzheimer’s disease and the institute’s broader clinical guideline on the management of dementia.